Comments
Loading...

4D Molecular Therapeutics Informe de interés a corto plazo

FDMTNASDAQ
Logotipo presentado por Benzinga Data
$10.34
-0.46-4.26%
al cierre: Nov 20, 4:00 PM EST
$10.20
-0.14-1.35%
After hour: 6:00 PM EST

Informe de interés en corto

El interés corto en 4D Molecular Therapeutics Inc (NASDAQ:FDMT) ha aumentado durante el último período de informe, aumentando en aumento desde 4.22M hasta 4.27M. Esto representa el 7.72% de las acciones disponibles públicamente de la empresa.

Basado en el volumen promedio reciente de 980.07K acciones negociadas por día, tomaría 4.36 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.

Interés en corto
4.27M
Interés en corto %
7.72%
Días para cubrir
4.36
Get Alert
FDMT
4D Molecular Therapeutics, Inc
10/31/2025
11/11/2025
7.72%
55,305,878
4,271,739
980,066
4.36
FDMT
4D Molecular Therapeutics, Inc
10/15/2025
10/24/2025
9.40%
44,873,270
4,219,162
735,599
5.74
FDMT
4D Molecular Therapeutics, Inc
09/30/2025
10/09/2025
10.00%
44,873,270
4,488,864
779,153
5.76
FDMT
4D Molecular Therapeutics, Inc
09/15/2025
09/24/2025
10.46%
44,873,270
4,691,697
559,252
8.39
FDMT
4D Molecular Therapeutics, Inc
08/29/2025
09/10/2025
9.57%
44,873,270
4,295,623
655,621
6.55
FDMT
4D Molecular Therapeutics, Inc
08/15/2025
08/26/2025
9.23%
44,873,270
4,142,441
4,040,836
1.03
FDMT
4D Molecular Therapeutics, Inc
07/31/2025
08/11/2025
8.32%
44,495,445
3,703,248
459,039
8.07
FDMT
4D Molecular Therapeutics, Inc
07/15/2025
07/24/2025
8.13%
44,495,445
3,619,133
332,098
10.9
FDMT
4D Molecular Therapeutics, Inc
06/30/2025
07/10/2025
8.73%
44,495,445
3,885,430
460,765
8.43
FDMT
4D Molecular Therapeutics, Inc
06/13/2025
06/25/2025
9.38%
44,495,445
4,171,819
530,228
7.87
FDMT
4D Molecular Therapeutics, Inc
05/30/2025
06/10/2025
9.78%
44,495,445
4,352,742
396,858
10.97
FDMT
4D Molecular Therapeutics, Inc
05/15/2025
05/27/2025
10.49%
44,495,445
4,668,859
517,013
9.03
FDMT
4D Molecular Therapeutics, Inc
04/30/2025
05/09/2025
11.33%
44,495,445
5,039,643
424,039
11.88
FDMT
4D Molecular Therapeutics, Inc
04/15/2025
04/25/2025
11.71%
44,422,430
5,200,870
995,479
5.22
FDMT
4D Molecular Therapeutics, Inc
03/31/2025
04/09/2025
11.38%
44,422,430
5,057,335
706,355
7.16
FDMT
4D Molecular Therapeutics, Inc
03/14/2025
03/25/2025
11.32%
44,422,430
5,028,368
721,909
6.97
FDMT
4D Molecular Therapeutics, Inc
02/28/2025
03/11/2025
11.80%
44,422,430
5,241,024
601,496
8.71
FDMT
4D Molecular Therapeutics, Inc
02/14/2025
02/26/2025
13.88%
44,422,430
6,167,568
1,323,298
4.66
FDMT
4D Molecular Therapeutics, Inc
01/31/2025
02/11/2025
16.65%
44,422,430
7,397,347
639,933
11.56
FDMT
4D Molecular Therapeutics, Inc
01/15/2025
01/27/2025
17.27%
44,422,430
7,672,441
776,503
9.88
FDMT
4D Molecular Therapeutics, Inc
12/31/2024
01/10/2025
17.98%
44,422,430
7,986,854
1,351,357
5.91
FDMT
4D Molecular Therapeutics, Inc
12/13/2024
12/24/2024
20.07%
44,422,430
8,917,026
588,395
15.15
FDMT
4D Molecular Therapeutics, Inc
11/29/2024
12/10/2024
19.19%
44,422,430
8,522,668
999,899
8.52
FDMT
4D Molecular Therapeutics, Inc
11/15/2024
11/26/2024
17.62%
44,422,430
7,827,058
821,166
9.53
FDMT
4D Molecular Therapeutics, Inc
10/31/2024
11/11/2024
16.31%
50,164,311
8,182,326
741,545
11.03
FDMT
4D Molecular Therapeutics, Inc
10/15/2024
10/24/2024
18.92%
50,164,311
9,490,542
913,610
10.39
FDMT
4D Molecular Therapeutics, Inc
09/30/2024
10/09/2024
21.78%
50,164,311
10,925,855
1,429,600
7.64
FDMT
4D Molecular Therapeutics, Inc
09/13/2024
09/24/2024
18.97%
50,164,311
9,517,746
410,862
23.17
FDMT
4D Molecular Therapeutics, Inc
08/30/2024
09/11/2024
19.68%
50,164,311
9,873,630
449,647
21.96
FDMT
4D Molecular Therapeutics, Inc
08/15/2024
08/26/2024
19.84%
50,164,311
9,953,253
580,789
17.14
FDMT
4D Molecular Therapeutics, Inc
07/31/2024
08/09/2024
19.00%
50,164,311
9,530,709
2,033,191
4.69
FDMT
4D Molecular Therapeutics, Inc
07/15/2024
07/24/2024
20.73%
49,898,133
10,344,746
547,889
18.88
FDMT
4D Molecular Therapeutics, Inc
06/28/2024
07/10/2024
19.82%
49,898,133
9,891,860
909,558
10.88
FDMT
4D Molecular Therapeutics, Inc
06/14/2024
06/26/2024
19.44%
49,898,133
9,701,494
586,920
16.53
FDMT
4D Molecular Therapeutics, Inc
05/31/2024
06/11/2024
19.19%
49,898,133
9,575,719
480,501
19.93
FDMT
4D Molecular Therapeutics, Inc
05/15/2024
05/24/2024
19.33%
49,898,133
9,646,011
421,320
22.89
FDMT
4D Molecular Therapeutics, Inc
04/30/2024
05/09/2024
19.28%
49,898,133
9,622,548
433,843
22.18
FDMT
4D Molecular Therapeutics, Inc
04/15/2024
04/24/2024
19.93%
49,352,193
9,834,818
812,049
12.11
FDMT
4D Molecular Therapeutics, Inc
03/28/2024
04/09/2024
18.88%
49,352,193
9,317,980
673,496
13.84
FDMT
4D Molecular Therapeutics, Inc
03/15/2024
03/26/2024
21.34%
39,825,055
8,500,234
857,701
9.91
FDMT
4D Molecular Therapeutics, Inc
02/29/2024
03/11/2024
20.95%
39,825,055
8,344,171
678,962
12.29
FDMT
4D Molecular Therapeutics, Inc
02/15/2024
02/27/2024
17.93%
39,385,395
7,061,371
3,558,792
1.98
FDMT
4D Molecular Therapeutics, Inc
01/31/2024
02/09/2024
9.74%
39,386,550
3,835,135
481,536
7.96
FDMT
4D Molecular Therapeutics, Inc
01/12/2024
01/24/2024
8.78%
32,800,535
2,880,449
349,325
8.25
FDMT
4D Molecular Therapeutics, Inc
12/29/2023
01/10/2024
9.82%
32,800,535
3,220,145
490,653
6.56
FDMT
4D Molecular Therapeutics, Inc
12/15/2023
12/27/2023
12.00%
32,800,535
3,934,660
391,511
10.05
FDMT
4D Molecular Therapeutics, Inc
11/30/2023
12/11/2023
10.97%
32,800,535
3,597,841
217,931
16.51
FDMT
4D Molecular Therapeutics, Inc
11/15/2023
11/27/2023
11.49%
32,800,535
3,767,763
350,884
10.74